24 days ago
XENE
AnalystsTessa RomeroTessa Romero's Stock Forecasts
AnalystsTessa Romero
Sectors:
Industries:
Analyst Ranking
Top 14%
#702 out of 5185 analysts
Average Return
+18.95%
Win Rate
48%29 out of 60
Risk vs Reward
Poor
Good
Tessa Romero's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +397.74% | $7.07 | $35.19 | 2024-10-03 - 2025-10-02 | Strong Buy |
Dyne Therapeutics IncDYN | +307.09% | $10.58 | $43.07 | 2023-08-09 - 2024-08-08 | Strong Buy |
Biohaven LtdBHVN | +174.33% | $14.65 | $40.19 | 2023-01-04 - 2024-01-03 | Strong Buy |
Lexeo Therapeutics IncLXEO | +172.43% | $2.72 | $7.41 | 2025-05-30 - 2026-01-30 | Strong Buy |
Edgewise Therapeutics IncEWTX | +132.39% | $7.75 | $18.01 | 2023-06-30 - 2024-06-28 | Strong Buy |
Tessa Romero Analyst Color
Get additional color on Tessa Romero's coverage of popular stocks
2 months ago
XENE
2 months ago
SRRK
3 months ago
EWTX
a year ago
BHVN
a year ago
CYTK
2 years ago
BHVN
Tessa Romero's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dyne Therapeutics IncDYN | 8 | Hold | $16.00 | -10.56% | Maintains | 13 days ago |
Cytokinetics IncCYTK | 6 | Strong Buy | $74.00 | +17.11% | Maintains | 13 days ago |
Xenon Pharmaceuticals IncXENE | 4 | Strong Buy | $62.00 | +51.18% | Maintains | 24 days ago |
Agios Pharmaceuticals IncAGIO | 8 | Hold | $25.00 | -8.89% | Maintains | a month ago |
Oculis Holding AgOCS | 1 | Strong Buy | $38.00 | +33.57% | Initiates Coverage On | a month ago |
Biohaven LtdBHVN | 8 | Strong Buy | $15.00 | +26.80% | Maintains | 2 months ago |
Scholar Rock Holding CorpSRRK | 5 | Strong Buy | $47.00 | +6.00% | Maintains | 2 months ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Sell | $263.00 | +7,457.47% | Downgrades | 2 months ago |
Acadia Pharmaceuticals IncACAD | 11 | Strong Buy | $31.00 | +23.36% | Maintains | 3 months ago |
Edgewise Therapeutics IncEWTX | 10 | Strong Buy | $34.00 | +20.78% | Maintains | 3 months ago |
Lexeo Therapeutics IncLXEO | 2 | Strong Buy | $10.00 | +34.95% | Maintains | 8 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | a year ago |
Neumora Therapeutics IncNMRA | 4 | Hold | $15.00 | N/A | Downgrades | a year ago |
Eyepoint Pharmaceuticals IncEYPT | 3 | Strong Buy | $29.00 | N/A | Maintains | a year ago |
Y Mabs Therapeutics IncYMAB | 5 | Strong Sell | $7.00 | N/A | Maintains | 2 years ago |
Seres Therapeutics IncMCRB | 1 | Hold | $140.00 | N/A | Initiates Coverage On | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $36.00 | N/A | Maintains | 4 years ago |
Orchard Therapeutics PLCORTX | 1 | Strong Buy | $150.00 | N/A | Assumes | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.